Show metadata Hide metadata

(19)

(11)

2 710 549

(13)

(51)

IPC

C07D471/04(2006-01-01)

C07D473/34(2006-01-01)

C07D519/00(2006-01-01)

A61K31/5377(2006-01-01)

A61P11/00(2006-01-01)

A61P17/00(2006-01-01)

A61P19/00(2006-01-01)

A61P35/00(2006-01-01)

A61P37/00(2006-01-01)

(21) (22)

Application

2017134110, 2016-03-29

(24)

Start date

2016-03-29

(22)

Actual filing date

2016-03-29

(45)

Published

2019-12-27

(72)

Inventor

Verma, Ashwani, KumarPatel, PriyankaGorla, Suresh, KumarAmale, Sagar, RamdasSurase, Yogesh, BabanSamby, Kirandeep, Kaur

(73)

Holder

Daiichi Sankyo Company, Limited

PYRAZOLE DERIVATIVE SUITABLE AS PI3K INHIBITOR Russian patent published in 2019 - IPC C07D471/04 C07D473/34 C07D519/00 A61K31/5377 A61P11/00 A61P17/00 A61P19/00 A61P35/00 A61P37/00

Abstract RU 2710549 C2

FIELD: medicine; pharmaceuticals.

SUBSTANCE: invention relates to a pyrazole derivative of formula (I) and a pharmaceutical composition containing a compound of formula (I) as an active ingredient, methods for preparing it and methods for using it.

EFFECT: technical result is obtaining novel compounds which can be used as a phosphatidyl inositol-3-kinase (PI3K) inhibitor, which can be used for treating or preventing mediated diseases.

21 cl, 5 tbl

Similar patents RU2710549C2

Title	Year	Author	Number
BICYCLIC COMPOUND AND USE THEREOF FOR SUV39H2 INHIBITION	2016	Matsuo, Yo Hisada, Shoji Nakamura, Yusuke Chakrabarti, Anjan Rawat, Manish Rai, Sanjay Satyanarayana, Arvapalli, Venkata Duan, Zhiyong Talukdar, Arindam Ravula, Srinivas Decornez, Helene	RU2729187C1
PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA	2013	Achab Abdelgkhani Abe Altman Majkl D. Deng Jongki Gyuzi Timoti Kattar Solomon Katts Dzhejson D. Metot Dzhon L. Chzhou Khua Makgovan Meredet Kristofer Mettyu P. Garsiya Yudit Entoni Nevill Dzhon Fradera Linas Fransesk Ksaver Mu Chanvej Chzhan Sisin Chzhan Zhun Fong Kin Chiu Len Syanshen	RU2658006C2
1H-PYRAZOLO[3,4-B]PYRIDINES AND THEIR THERAPEUTIC APPLICATIONS	2013	Khud Dzhon Ks Sunil Kumar Uollejs Devid Mark	RU2689141C2
HETEROARYL COMPOUNDS AS TKB INHIBITORS AND USE THEREOF	2015	Gaillard, Pascale Seenisamy, Jeyaprakashnarayanan Gardberg, Anna Johnson, Theresa L. Sherer, Brian A. Goutopoulos, Andreas Won, Annie Cho Jones, Reinaldo Neagu, Constantin Qiu, Hui Caldwell, Richard D. Potnick, Justin Liu-Bujalski, Lesley	RU2742122C2
PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA	2013	Achab Abdelgkhani Abe Altman Majkl D. Deng Jongki Kattar Solomon Katts Dzhejson D. Metot Dzhon L. Chzhou Khua Makgovan Meredet Kristofer Mettyu P. Garsiya Yudit Entoni Nevill Dzhon Fradera Linas Fransesk Ksaver Yan Lipin Mu Chanvej Van Syaona Shi Fen E Bajtszyun Chzhan Sisin Chzhao Syaoli Chzhan Zhun Fong Kin Chiu Len Syanshen	RU2661896C2
INDAZOLE-3-CARBOXAMIDES AND THEIR USE AS WNT/β-CATENIN SIGNAL INHIBITORS	2012	Khud Dzhon Ks Sunil Kumar	RU2627693C2
MODULATORS OF NUCLEAR RECEPTORS	2016	Argiriadi, Maria, A. Breinlinger, Eric, C. Cusack, Kevin, P. Hobson, Adrian, D. Potin, Dominique Barth, Martine Amaudrut, Jerome Poupardin, Olivia Mounier, Laurent Kort, Michael, E.	RU2715897C2
METHOD FOR TREATMENT OF ALLERGY BY USING SUBSTITUTED PYRAZOLES	2001	Kaj Kh'Jui Ehdvards Dzhejms P. Gu Jin Karlsson Lars Meduna Stiven P. Pajo Barbara A. Sun Sikvan Termond Robin L. Vej Dzhianmej	RU2259202C2
SUBSTITUTED [1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-7-YL COMPOUNDS AS THE INHIBITORS OF PDE2	2015	Brajtenbukher Dzhejms Fristoun Gremi Gomez Loran Lemus Robert Li Kiv Makkarrik Margaret Verner Uilyam Vikers Troj	RU2659070C9
HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS	2018	Vadivelu, Saravanan Rajagopal, Sridharan Burri, Raghunadha Reddy Garapaty, Shivani Sivanandhan, Dhanalakshmi Thakur, Manish Kumar Natarajan, Tamizharasan Swamy, Indu N Nagaraju, Nagendra Kanagaraj, Subramaniam Mohd, Zainuddin Sarkar, Sayantani Samanta, Swapan Kumar Hariprakash	RU2797822C2

RU 2 710 549 C2

Authors

Verma, Ashwani, Kumar

Patel, Priyanka

Gorla, Suresh, Kumar

Amale, Sagar, Ramdas

Surase, Yogesh, Baban

Samby, Kirandeep, Kaur

Dates

2019-12-27—Published

2016-03-29—Filed